UChicago Medicine earns 13th consecutive ‘A’ in patient safety

The University of Chicago Medicine earned its 13th consecutive “A” in patient safety from The Leapfrog Group, a prominent hospital-watchdog organization. The grade, announced on April 24, 2018, makes UCM one of only 49 hospitals in the country to achieve an “A” in every grading update since the launch of the Safety Grade in 2012.      

Specific Bacteria in Small Intestine are Crucial for Fat Absorption

Although the vast majority of research on the gut microbiome has focused on bacteria in the large intestine, a new study — one of a few to concentrate on microbes in the upper gastrointestinal tract — shows how the typical calorie-dense western diet can induce expansion of microbes that promote the digestion and absorption of high-fat foods. Several studies have shown that these bacteria can multiply within 24 to 48 hours in the small bowel in response to consumption of high-fat foods. The findings from this work suggest that these microbes facilitate production and secretion of digestive enzymes into the … Read More

Continuous glucose monitors proven cost-effective, add to quality of life for diabetics

Continuous glucose monitors (CGM) offer significant, daily benefits to people with type 1 diabetes, providing near-real time measurements of blood sugar levels, but they can be expensive. A new study by researchers from the University of Chicago Medicine, based on a 6-month clinical trial, finds that use of a CGM is cost-effective for adult patients with type 1 diabetes when compared to daily use of test strips. The results are well within the thresholds normally used by insurance plans to cover medical devices. During the trial, CGMs improved overall blood glucose control for the study group and reduced hypoglycemia, or … Read More

New York Times – Anna Volerman, MD explains practices to avoid life-threatening allergic reactions

Anaphylaxis is the scary end of allergy, the kind of reaction that can kill. It can happen almost immediately after the exposure — being stung by the bee, eating the peanut — and it can move fast. In anaphylaxis, your immune system turns against you with a vengeance, revs up and releases histamines and other chemicals that set off a range of dangerous physiological changes. More

National survey ranks Biological Sciences Division #13 and Pritzker #18

The University of Chicago Biological Sciences Division moved up one notch to No. 13 — with the paleontology program retaining its top rating and the ecology & evolution program placing 8th — in the 2019 edition of U.S. News & World Report‘s survey of the country’s best biological sciences doctoral programs. Meanwhile, the Pritzker School of Medicine placed No. 18 among the best medical schools for research.   More

2018-2019 Pilot & Feasibility Grants Program of the NIH/NIDDK-sponsored Chicago Center for Diabetes Translation Research-Deadline 5/11/2018

Funding Opportunity for Pilot & Feasibility Projects through the University of Chicago’s NIDDK/NIH-Sponsored Chicago Center for Diabetes Translation Research SUBMISSION DEADLINE: Friday, May 11th, 2018 by 5:00 p.m. Central Time. We are pleased to announce the availability of funds for Pilot and Feasibility Projects with a start date of: August 1, 2018 Purpose: Pilot & Feasibility Studies are research projects aimed at: 1) Attracting more junior investigators of the faculty into the area of diabetes-related type II translational research;2) Allowing more established investigators who are not currently engaged in diabetes type II translational research to extend their investigations into this … Read More

Taking a standard prostate cancer drug with food boosts impact, lowers cost

By taking a high-cost drug with a low-fat meal — instead of on an empty stomach, as prescribed — prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent, according to a new study in the March 28, 2018, issue of the Journal of Clinical Oncology (JCO). More https://www.uchospitals.edu/cancer-articles/taking-a-standard-prostate-cancer-drug-with-food-boosts-impact-lowers-cost